CLINICAL AND BIOCHEMICAL ASPECTS OF LITHIUM THERAPY

被引：0
作者：
CLOWER, CG
SAVAGE, C
MESSIHA, F
机构：
来源：
DISEASES OF THE NERVOUS SYSTEM | 1971年 / 32卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：127 / &
相关论文
共 13 条
[1]  
BAER L, 1970, ARCH GEN PSYCHIAT, V22, P108
[2]  
BARBAU A, 1961, SCIENCE, V133, P1096
[3]  
BARBEAU A, 1968, AGGRESSOLOGY, V9, P2
[4]   BIOCHEMISTRY OF AFFECTIVE DISORDERS [J].
COPPEN, A .
BRITISH JOURNAL OF PSYCHIATRY, 1967, 113 (504) :1237-+
[5]  
HAGGENDAL J, 1966, ACTA PHYSL SCAND, V166, P223
[6]   DOPAMIN (3-HYDROXYTYRAMIN) IM ZENTRALNERVENSYSTEM UND SEINE BEZIEHUNG ZUM PARKINSON-SYNDROM DES MENSCHEN [J].
HORNYKIEWICZ, O .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1962, 87 (36) :1807-+
[7]   EVOKED RELEASE OF NOREPINEPHRINE AND SEROTONIN FROM BRAIN SLICES - INHIBITION BY LITHIUM [J].
KATZ, RI ;
CHASE, TN ;
KOPIN, IJ .
SCIENCE, 1968, 162 (3852) :466-&
[8]  
KETY SS, 1966, PHARMACOL REV, V18, P787
[9]  
Messiha F S, 1970, Nature, V225, P868, DOI 10.1038/225868a0
[10]   THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE-DISORDERS - A REVIEW OF SUPPORTING EVIDENCE [J].
SCHILDKRAUT, JJ .
AMERICAN JOURNAL OF PSYCHIATRY, 1965, 122 (05) :509-522
12